You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 4, April 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group

R. J. Ellis, R. Deutsch, R. K. Heaton, T. D. Marcotte, J. A. McCutchan, J. A. Nelson, I. Abramson, L. J. Thal, J. H. Atkinson, M. R. Wallace and I. Grant
Department of Neurosciences, University of California, Department of Medicine, San Diego, USA. roellis@ucsd.edu

OBJECTIVE: To determine if mortality is increased in individuals with human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders less severe than frank dementia. DESIGN: A prospective cohort study; median duration of follow-up was 2.4 years. Kaplan-Meier analysis and Cox proportional hazards models were used to compare survival times according to neurocognitive classification. SETTING: University-based research unit. PARTICIPANTS: A volunteer sample of 414 individuals seropositive for HIV-1. Subjects were classified at their baseline evaluation as neuropsychologically (NP) normal or abnormal (impaired in > or = 2 NP test domains). A subgroup of NP abnormal subjects met operational criteria for HIV-associated minor cognitive motor disorder; the remaining subjects were designated NP impaired. Subjects with frank dementia were excluded. MAIN OUTCOME MEASURE: Mortality. RESULTS: At the baseline evaluation, 256 (62%) of 414 subjects were designated normal; 109 (26%). NP impaired; and 49 (12%), minor cognitive motor disorder. One hundred six participants (26%) died during follow-up. Compared with the NP normal group, the unadjusted relative risk (RR) of death for all NP abnormal subjects (minor cognitive motor disorder and NP impaired) was significantly increased (RR, 1.7; 95% confidence interval [CI], 1.2-2.6; P < .005). After adjusting for concurrently measured predictors of survival (CD4 lymphocyte counts, Centers for Disease Control and Prevention HIV disease classification, hemoglobin concentration, and serum beta 2-microglobulin) in proportional hazards models, mortality for all NP abnormal subjects remained elevated (RR, 1.8; 95% CI, 1.2-2.8; P < .01). The elevation in mortality risk for subjects with minor cognitive motor disorder was statistically significant (RR, 2.2; 95% CI, 1.2-3.8; P < .01); for NP impaired subjects it was marginally significant (RR, 1.6; 95% CI, 1.0-2.8; P = .06). CONCLUSIONS: The HIV-infected individuals with NP impairment had a higher risk of dying than those without impairment. This was particularly true for those meeting syndromic diagnostic criteria.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Evaluation of Neurocognitive Status and Markers of Immune Activation as Predictors of Time to Death in Advanced HIV Infection
Sevigny et al.
Arch Neurol 2007;64:97-102.
ABSTRACT | FULL TEXT  

Interleukin-1beta Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors
Viviani et al.
J. Biol. Chem. 2006;281:30212-30222.
ABSTRACT | FULL TEXT  

Glutamate metabolism in HIV-infected macrophages: implications for the CNS
Porcheray et al.
Am. J. Physiol. Cell Physiol. 2006;291:C618-C626.
ABSTRACT | FULL TEXT  

Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline
Thompson et al.
Proc. Natl. Acad. Sci. USA 2005;102:15647-15652.
ABSTRACT | FULL TEXT  

Correlation of In Vivo Neuroimaging Abnormalities With Postmortem Human Immunodeficiency Virus Encephalitis and Dendritic Loss
Archibald et al.
Arch Neurol 2004;61:369-376.
ABSTRACT | FULL TEXT  

Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion
Marcotte et al.
Arch Neurol 2003;60:1406-1412.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus-Associated Dementia
Clifford
Arch Neurol 2000;57:321-324.
FULL TEXT  

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
Ellis et al.
Neurology 2000;54:927-936.
ABSTRACT | FULL TEXT  

Progressive Cerebral Volume Loss in Human Immunodeficiency Virus Infection: A Longitudinal Volumetric Magnetic Resonance Imaging Study
Stout et al.
Arch Neurol 1998;55:161-168.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.